Zobrazeno 1 - 10
of 51
pro vyhledávání: '"B. Tschechne"'
Publikováno v:
Case Reports in Oncology, Vol 3, Iss 2, Pp 154-159 (2010)
Background: Second as well as higher-line therapies have a significant influence on progression-free and overall survival of metastatic colorectal cancer patients. However, treatment of late-stage disease remains suboptimal. Therefore, the introducti
Externí odkaz:
https://doaj.org/article/131198ee661441b4bf6ca575a198dd17
Autor:
Mark-Oliver Zahn, B Tschechne, A R Rotmann, Siegfried Haas, B. Gerber, Jörg Schilling, M Konias, Meinolf Karthaus, U Schwindel
Publikováno v:
Blood. 136:44-45
Introduction: Chemotherapy-induced nausea and vomiting (CINV) is a common and distressing side effect that has a detrimental impact on QoL. For pts receiving highly emetogenic chemotherapy (HEC), which includes those on anthracycline-cyclophosphamide
Publikováno v:
Annals of Hematology
Bendamustine has demonstrated clinical activity and a favorable safety profile as monotherapy or in combination with rituximab in lymphoid malignancies. As interventional trials do not always reflect clinical reality, we were interested in the treatm
Autor:
O. Harlin, B. Tschechne, J. Wamhoff, M. Franzem, Norbert Marschner, B. Klement, Hans Tesch, R. Rohrberg, T. Steinmetz
Publikováno v:
Annals of Oncology
Background Intravenous (i.v.) iron can improve anaemia of chronic disease and response to erythropoiesis-stimulating agents (ESAs), but data on its use in practice and without ESAs are limited. This study evaluated effectiveness and tolerability of f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 3, Iss 2, Pp 154-159 (2010)
Case Reports in Oncology, Vol 3, Iss 2, Pp 154-159 (2010)
BACKGROUND: Second as well as higher-line therapies have a significant influence on progression-free and overall survival of metastatic colorectal cancer patients. However, treatment of late-stage disease remains suboptimal. Therefore, the introducti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a663f758a7d59bc819daba8906f0d720
http://resolver.sub.uni-goettingen.de/purl?gs-1/6903
http://resolver.sub.uni-goettingen.de/purl?gs-1/6903
Publikováno v:
Senologie - Zeitschrift für Mammadiagnostik und -therapie. 5
Autor:
Bahriye Aktas, F. Foerster, Andreas Schneeweiss, Christoph Salat, M. Welslau, B. Tschechne, M Geberth, Hans Tesch, Martina Schmidt
Publikováno v:
European Journal of Cancer. 47:S351-S352
Autor:
Hans Tesch, B. Tschechne, B. Klement, Norbert Marschner, R. Rohrberg, G. Virgin, M. Franzem, J. Wamhoff, H. Steinmetz, B. Rzychon
Publikováno v:
European Journal of Cancer. 47:S221-S222